Kao WH, Yang YS, Lan CL, Lo WC, et al. Romosozumab mitigates progression from radiological to symptomatic adjacent-level fractures compared to teriparatide. Osteoporos Int 2025 Dec 16. doi: 10.1007/s00198-025-07813.
PMID: 41400654